Sage Journals: Discover world-class research

Retricted access

Review article

First published 2022-6

Veliparib for the treatment of solid malignancies

Rony R George, Rimisha Thomas, Anna Davice [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2018-04

Effects of Veliparib on Microglial Activation and Functional Outcomes after Traumatic Brain Injury in the Rat and Pig

Karen-Amanda Irvine, Robin K. Bishop, Seok Joon Won [...]

Journal of Neurotrauma

Retricted access

Brief report

First published 2018-09

Does the Poly (ADP-Ribose) Polymerase Inhibitor Veliparib Merit Further Study for Cancer-Associated Weight Loss? Observations and Conclusions from Sixty Prospectively Treated Patients

Jason D. Doles, Kelly A. Hogan, Jennifer O'Connor [...]

Journal of Palliative Medicine

Retricted access

Research article

First published 2023-3

Effect of PARP-1 Inhibition on Rotator Cuff Healing: A Feasibility Study Using Veliparib in a Rat Model of Acute Rotator Cuff Repair

Michael B. Künzler, Michelle H. McGarry, Masaki Akeda [...]

The American Journal of Sports Medicine

Open access

Research article

First published 2021

Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1 / 2 mutations and hormone receptor status from the phase-3 BROCADE3 trial

Jean-Pierre Ayoub, Hans Wildiers, Michael Friedlander [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2021

The role of PARP inhibitors in BRCA mutated pancreatic cancer

Jeffrey Chi, Su Yun Chung, Ruwan Parakrama [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2023-3

Cost-effectiveness of poly-(ADP-ribose) polymerase (PARP)-inhibitors for the maintenance treatment after responding to first- and second-line chemotherapy in advanced ovarian cancer

Jacopo Giuliani, Beatrice Mantoan, Lucrezia Ferrario [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2018

Inhibitors targeting CDK4/6,PARP and PI3K in breast cancer: a review

Siti Muhamad Nur Husna, Hern-Tze Tina Tan, Rohimah Mohamud [...]

Therapeutic Advances in Medical Oncology

Retricted access

Research article

First published 2019-1

Can Poly (ADP-Ribose) Polymerase Inhibitors Palliate Paclitaxel-Induced Peripheral Neuropathy in Patients With Cancer?

Ryan A. Balko, Andrea Wahner Hendrickson, Megan E. Grudem [...]

American Journal of Hospice and Palliative Medicine®

Retricted access

Review article

First published 2016-9

The Current Status of PARP Inhibitors in Ovarian Cancer

Jennifer McLachlan, Angela George, Susana Banerjee

Tumori Journal

Search results